ERNEST MARIO
CIK 1180469 · last filed 2024-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$12.68M
Companies
15
Total Filings
301
Lifetime Open-Market Net
-$44.39M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SLNO | Director | 214,855 | $53.01 | $11.39M | $0 | 20 | 2024-06-10 |
| HYPERION DEFI, INC. (EYEN) Delisted | Director | 382,706 | $15.82 | $6.05M | $1.19M | 8 | 2021-11-22 |
| Kindred Biosciences, Inc. (KIN) Delisted | Director | 125,000 | $9.25 | $1.16M | $387.0K | 14 | 2021-01-22 |
| CELGENE CORP /DE/ (CELGZ) Delisted | Director | 0 | — | — | -$26.01M | 51 | 2019-11-22 |
| SOLENO THERAPEUTICS INC (SLNOW) Delisted | Director | 471,218 | — | — | $0 | 12 | 2019-06-12 |
| TNXP | Director | 113,822 | $11.35 | $1.29M | $1.03M | 30 | 2018-06-27 |
| CHIMERIX INC (CMRX) Delisted | Director | 121,072 | $8.54 | $1.03M | $1.22M | 36 | 2018-05-21 |
| SOLENO THERAPEUTICS INC (CAPNW) Delisted | Director | 1,795,929 | — | — | $0 | 2 | 2017-05-09 |
| SOLENO THERAPEUTICS INC (CAPN.W) Delisted | Director | 1,789,678 | — | — | $522.7K | 20 | 2016-10-11 |
| BOSTON SCIENTIFIC CORP (BSXw) Delisted | Director | 86,032 | — | — | -$4.09M | 47 | 2015-11-17 |
| XENOPORT INC (XNPT) Delisted | Director | 88,750 | — | — | $194.8K | 6 | 2015-05-21 |
| VIVUS INC (VVUS) Delisted | Director | 81,125 | — | — | $758.9K | 5 | 2013-05-30 |
| PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted | Director | 0 | — | — | -$20.28M | 31 | 2011-12-06 |
| CELGENE CORP /DE/ (CELG) Delisted | Director | 23,185 | — | — | $687.4K | 9 | 2010-06-18 |
| Alexza Pharmaceuticals Inc. (ALXA) Delisted | Director | 18,181 | — | — | $0 | 2 | 2007-07-26 |
Recent Filings · Page 2 of 31
301 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-11-02 | SLNO | Grant (A) | +26,888 | $0 | EDGAR |
| 2021-08-03 | SLNO | Grant (A) | +21,978 | $20.0K | EDGAR |
| 2021-06-04 | SLNO | Grant (A) | — | $0 | EDGAR |
| 2021-05-04 | SLNO | Grant (A) | +16,529 | $20.0K | EDGAR |
| 2021-02-02 | SLNO | Grant (A) | +8,928 | $0 | EDGAR |
| 2021-01-22 | Kindred Biosciences, Inc. (KIN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-01-19 | HYPERION DEFI, INC. (EYEN) Delisted | Exer (X) | +41,216 | $93.6K | EDGAR |
| 2021-01-12 | SLNO | Grant (A) | — | $0 | EDGAR |
| 2020-11-03 | SLNO | Grant (A) | +10,057 | $17.5K | EDGAR |
| 2020-09-15 | HYPERION DEFI, INC. (EYEN) Delisted | Grant (A) | +7,288 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.